Replies to post #38125 on Premier Biomedical Inc (BIEI)

[tiller]

Not nearly enough.
IMO.

GLTA

[it_happens]

Cancer trials are much more costly. The 600k is most likely for the PBPMS division and could include purchase of raw materials for current and future products, manufacturing tooling, packaging, inventory accumulation, etc.